No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
MY Stock MarketDetailed Quotes
0148WC SUNZEN-WC
- 0.145
- +0.005+3.57%
15min DelayNot Open Jul 24 16:35 CST
0.145High0.140Low
0.145High0.140Low3.89MVolume0.145Open0.140Pre Close563.86KTurnover0.15052wk High0.00%Turnover Ratio0Shares0.14052wk Low--EPS TTM0Float Cap0.150Historical High--P/E (Static)0Shs Float0.140Historical Low--EPS LYR3.57%Amplitude--Dividend TTM--P/B100Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
News
Does Sunzen Biotech Berhad (KLSE:SUNZEN) Deserve A Spot On Your Watchlist?
N2N, SSB8, Notion, Sunzen, Orgabio, VLB, JCY, Amway, Fajar, AHB
IGB, Paragon, GHL, Sunzen, Aneka, SNS, VSTECS
Sunzen Biotech Berhad's (KLSE:SUNZEN) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Sunzen Biotech Shelves Plans of MYR4.3 Million Stake Acquisition in Farmer International
Sunzen Biotech to End Operations of Loss-Making Animal Health Unit
Comments
Sunzen Biotech (KLSE: 0148) is poised for a breakout for the continued uptrend beyond RM0.350, the key resistance level for the company. Both MA20/50 showed positive strengths with reduced selling pressure. Key support remained at RM0.345, which was formed after multi tests on the consolidation phase. Maintain BUY for Sunzen Biotech.
Support: RM0.345, RM0.320
Resistance: RM0.350, RM0.370
$SUNZEN(0148.MY$
Support: RM0.345, RM0.320
Resistance: RM0.350, RM0.370
$SUNZEN(0148.MY$
3
Understanding Sunzen Biotech
Sunzen Biotech Berhad has undergone significant business transformation and growth in recent years. Here are some key investment highlights to help you better understand the future prospects of this company.
Exiting from Animal Health Business. As of the latest record (FY2022), the animal health business accounted for 6.01% of the annual revenue but incurred a pre-tax loss of RM4.67 millio...
Sunzen Biotech Berhad has undergone significant business transformation and growth in recent years. Here are some key investment highlights to help you better understand the future prospects of this company.
Exiting from Animal Health Business. As of the latest record (FY2022), the animal health business accounted for 6.01% of the annual revenue but incurred a pre-tax loss of RM4.67 millio...
8
$SUNZEN(0148.MY$
they not only want more M＆A，they want the best M＆A. they will be more famous，benefit ecolite brands ，attract more investor
they not only want more M＆A，they want the best M＆A. they will be more famous，benefit ecolite brands ，attract more investor
5
$SUNZEN(0148.MY$
maybe is time to add some cw，is going to be dinosour soon
they try very hard to expand nosh to reach bursa requirement？more than 2％ cw had converted to ordianaryshares
maybe is time to add some cw，is going to be dinosour soon
they try very hard to expand nosh to reach bursa requirement？more than 2％ cw had converted to ordianaryshares
3
1
$SUNZEN(0148.MY$ 2.9mil queue added at 0.350 suddenly. Wow... Looks fishy... 🤔
7
Read more